https://www.businesswire.com/news/home/20260217411324/en/Instanosis-Xylazine-Rapid-Test-Urine-Granted-FDA-Breakthrough-Device-Designation
Instanosis Xylazine Rapid Test (Urine) Granted FDA Breakthrough Device Designation
Instanosis receives FDA Breakthrough Device Designation for its rapid xylazine urine test to support faster clinical detection.
rapid testxylazineurinegrantedfda